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3ABSTRACT
The growing number of x-ray examinations being routinely performed on patients 
using cone-beam computed tomography (CBCT) and multi-slice computed 
tomography (MSCT) devices have led to an emerging risk of and concern about 
radiation exposure. Typical CBCT absorbed doses range between 1–7 mGy, and 
thus values less than 1 mGy can be considered as low dose values. To date, most 
studies concerning effective dose assessment in the maxillofacial region use 
anthropomorphic phantoms in combination with thermoluminescent dosimeters 
(TLD). Recently, MOSFET dosimeters have been considered as a possible alternative 
to TLDs for in vitro dose assessment. The major benefit of MOSFET dosimeters is 
their real-time dose measurement capabilities.
All 20 MOSFET dosimeters were characterized for CBCT photon energy ranges, 
dose properties, and organ dose measurements using TLD dosimeters (I). The 
MOSFET dosimeter energy dependencies were evaluated for two photon energy 
ranges in order to encompass the typical mean photon energies used in dental 
radiology. Furthermore, the MOSFET dosimeter uncertainty was assessed by 
repetitive measurements at different doses. The MOSFET angular sensitivity was 
investigated using dental photon energies and soft tissue equivalent backscatter 
material. After MOSFET characterization, a dose measurement setup was developed. 
The setup comprised 20 MOSFET dosimeters that were placed into the allocated grid 
holes of an anthropomorphic RANDO phantom. The MOSFET dose measurement 
setup was validated using two different methods: Monte Carlo simulations and TLD 
dosimeters. The setup was used for organ and effective dose assessments resulting 
from supine, prone, and oblique phantom positions in the maxillofacial region using 
a novel cone beam computed tomography (CBCT) device and from two conventional 
dental CBCTs and one multi-slice computed tomography (MSCT) device.
All MOSFET dosimeters demonstrated a statistically insignificant energy 
dependency when using typical dental photon energies. Furthermore, the MOSFETs 
demonstrated excellent dose linearity and resulted in similar absorbed organ doses 
to those attained in the TLD measurements. The required low dose limit was 
achieved by averaging the values attained using eight MOSFET exposures. The 
MOSFET dosimeter angular dependency demonstrated a 5% standard deviation 
from the mean sensitivity value. The MOSFET dose assessment setup demonstrated 
similar effective doses to those attained using the Monte Carlo simulations and TLD 
measurements. Effective dose was strongly dependent on the vertical phantom 
positioning and minor vertical changes resulted in dose increases of up to 16%. The 
dose measurements acquired using the same FOV on all CBCT and MSCT devices 
4resulted in the following values: Planmed Verity CBCT scanner 247 µSv in supine, 
192 µSv in prone, and 134 µSv in oblique position, the ProMax 3D MAX CBCT 168 
µSv, i-CAT Next Generation 170 µSv, Philips Brilliance 64 MSCT 781 µSv.
The results of this study demonstrate that the mean photon energy dose 
dependency corrections are not required in typical dental energy ranges. 
Furthermore, averaging eight MOSFET exposures attained typical TLD low dose 
values. Due to their variation in angular sensitivity, MOSFET dosimeters should 
always be calibrated in clinical settings for beam geometry and the angular range of 
the CBCT exposure. Based on the results of the Monte Carlo simulations and TLD 
measurements, the MOSFET measurement setup constitutes a feasible method 
for low dose assessment in CBCT and MSCT devices in the maxillofacial region. 
When using the same FOV and exposure parameters, the effective doses obtained 
in the supine position were 29% higher (247 µSv) than those obtained in the prone 
position (192 µSv). When the prone and oblique positions were compared, the 
observed effective dose in the oblique position was 30% lower. Thus, optimal patient 
positioning can reduce the dose and subsequently minimize the radiation risks. 
In summary, the fast and dependable low- dose measurement setup presented in 
this thesis provides an effective means of CBCT dose assessment using a variety of 
exposure parameters, patient positioning, and FOVs. Further, the setup presented 
in this study can be used to test and develop CBCT devices that would subsequently 
produce lower effective doses. Since radiologists commonly only have access to the 
radiation output of different devices, they lack the possibility to assess the actual 
effective dose. Therefore, the setup developed in this thesis can also be utilized to 
increase the awareness of the lifetime radiation risks amongst radiologists leading 
to dose reduction 
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1 Introduction 
1 INTRODUCTION 
1.1 RADIATION FROM X-RAY SOURCES
Since their discovery by Wilhelm Röntgen in November 1895, x-ray devices have 
provided undeniable benefits in clinical imaging. However, the negative affects of 
using ionizing radiation on patients were soon realized. In x-ray examinations, 
billions of photons pass through a patient during a single exposure, and increases 
the probability of causing alterations to the DNA of cells. In addition, it must be 
noted that according to the linear threshold model (LNT) (ICRP 103, 2008), even 
one radiation particle may be harmful and cause DNA mutations that can result 
in malignant tumors. 
In order to minimize the lifetime radiation risks, both the number of examinations 
and the dose of each exposure should be reduced to the minimum and comply to the 
as low as reasonably achievable (ALARA) principle (ICRP 22, 1973). Additionally, 
one fundamental step in dose reduction is to develop measurement technologies 
that can reliably and effectively assess doses acquired during x-ray exposures. To 
date, the number of CBCT devices and subsequent imaging protocols is increasing, 
and several methods have been proposed to decrease the effective dose induced by 
CBCT devices. In the past, the most common method of reducing the dose induced 
by CBCT devices was to adjust the exposure parameters (Loubele 2008), (Ludlow 
2008), (Suomalainen 2009), (Kau 2005) and more recently by using novel low-
dose protocols (Xu 2012). The Health Protection Agency (HPA) Working Party has 
published guidelines on the safer use of CBCT devices (Holroyd 2010). Furthermore, 
the SEDENTEX Consortium (SEDENTEX 2011) and Pauwels et al. (Pauwels 2010) 
have published recommended effective dose ranges for CBCT devices. However, the 
number of exposures performed using low-dose CBCT devices worldwide is growing 
rapidly. Subsequently, the increase in exposures adds to the cumulative lifetime dose 
of the population and makes radiation safety an ever-growing concern. Therefore, 
new dose measurement systems are of fundamental importance.
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1.2 CBCT TECHNOLOGY
CBCT technology was first introduced in 1977 (Ganguly 2009) and later adapted for 
clinical use in 1982 at the Mayo Clinic Biodynamics Research Laboratory (Rochester, 
MN, USA) (Miracle 2009). Initial interest focused primarily on applications in 
angiography (Robb 1982) in which soft-tissue resolution could be sacrificed in favor of 
high temporal and spatial-resolving capabilities (Jaju 2014). Since that time, several 
CBCT systems have been developed for use both in the interventional suite and for 
general applications in CT angiography and radiation therapy (Wallace 2008). In 
1997, CBCT technology was adapted for maxillofacial purposes (Mozzo 1998), and 
in 1999 the first CBCT device (NewTom QR DVT 9000; Quantitative Radiology, 
Verona, Italy) was initially introduced in Europe (Mozzo 1998). The device became 
commercially available for maxillofacial imaging in 2001. Today, CBCT technology 
is becoming increasingly popular amongst maxillofacial radiologists and surgeons 
and has become instrumental in implant dentistry, orthodontics, endodontics, and 
maxillofacial surgery (Dawood 2009). 
During gantry rotation (180º-360º), the x-ray cone beam covers a cylindrical-
shaped field of view (FOV) that incorporates the entire captured volume of data 
(Dawood 2009). The 2D projection images are acquired during the gantry rotation 
by either using continuous or pulsed radiation from the x-ray source (Scarfe 2008). 
The benefits of pulsing are reduced dose and the minimization of gantry movement 
artifacts in the images. The resulting “frames” are recorded as a multiple 2D 
projection image set during gantry rotation using a flat panel detector or image 
intensifier coupled to a charge-coupled device (CCD). The number of planar 
projections typically ranges from 150 to more than 600 frames (Scarfe 2008). The 3D 
images commonly needed for diagnostic purposes are reconstructed from 2D images 
using a back projection reconstruction algorithm first described by Feldkamp et al. 
(Feldkamp 1984). To date, more sophisticated algorithms commonly use filtered 
back-projection to generate 3D volumetric data (Scarfe 2007).  
The major advantages of CBCT devices (Fig. 1.1), when compared to MSCT 
devices, are their shorter examination time (Scarfe 2008), high-contrast resolution 
(Suomalainen 2010), and low effective dose capabilities (Loubele 2009). However, 
CBCT devices induce scatter radiation that is considerably higher than that of MSCT 
devices. Further disadvantages of CBCT devices are increased beam hardening 
artifacts (Draenert 2007) and poor soft tissue contrast (Arai 1999), (Scarfe 2008). 
14
1 Introduction 
Fig. 1.1. Schematic presentation of CBCT scanning device 
1.3 DOSIMETERS AND DOSE ASSESSMENT METHODS
A radiation dosimeter is a device, instrument, or system that measures or evaluates, 
either directly or indirectly, the quantity of exposure, kerma, absorbed dose or 
equivalent dose, or their time derivatives (rates), or related quantities of ionizing 
radiation. A dosimeter along with its reader is referred to as a dosimetric system 
(Izewska 2005). Dosimeters measure the absorbed dose (D) that is defined as a 
quantity of radiation energy (Joule) deposited per unit mass (kg) of tissue (Gray = 
J/kg) (IAEA No. 457, 2007), (ICRU 33). 
At present, a number of different dose measurement methods are commonly 
used. Effective dose assessments can be performed either by using the computed 
tomography dose index (CTDI) or by using organ point dose measurements in 
anthropomorphic phantoms. The effective dose is typically calculated from the organ 
doses using tissue weighting factors recommended by the International Commission 
on Radiological Protection (ICRP) Publication 103 (ICRP 103).
CTDI: The CTDI has been most commonly applied for dose assessments in multi-
slice computed tomography (MSCT) devices (McCollough 2011), (Kim 2011a), (Yu 
2009), (Roxby 2009), (Pauwels 2012), (Lofthag-Hansen 2008), (Thilander-Klang 
2010). The CTDI was originally developed for fan beam (360º) spiral and helical 
gantry rotation CT dose assessment (Shope 1981). The major benefit of the CTDI is 
the standardized measurement method and the ease of use. However, one setback 
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of the CTDI in CBCT effective dose assessments is the need for dose conversion 
factors, especially when performing a partial gantry rotation (e.g. 210º) around 
the patient. Furthermore, the CTDI values are commonly measured using a 100 
mm long pencil chamber with the assumption that the collimated x-ray beam and 
penumbra are contained within the length of the dose meter. This does not apply 
to CBCT devices, however, where the FOV length is larger than the length of the 
pencil chamber (Boone 2007), (Mori 2005), (Pauwels 2012).
The effective doses caused by MSCT or CBCT devices are traditionally measured 
using anthropomorphic phantoms and different dosimeters. At present, the most 
commonly used dosimeters are thermoluminescent dosimeters (TLD), optically 
stimulated luminescent dosimeters (OSLD), radio-photoluminescence dosimeters 
(RPLD), and metal oxide semiconductor field effect transistor dosimeters (MOSFET).
TLD: Traditionally, effective dose assessments in the maxillofacial region 
have been performed using anthropomorphic phantoms combined with 
thermoluminescent dosimeters (TLD) (Ludlow 2003), (Kau 2005), (Ludlow 
2006), (Ludlow 2008), (Kiljunen 2008), (Roberts 2009), (Suomalainen 2009), 
(Pauwels 2010), (Qu 2010), (Rottke 2013). A review of TLD dosimeter history 
is presented by Aschan (Aschan 1999).
The benefit of TLDs is their capability to measure very low doses (Tarr 1998), 
(Dong 2002) and linear response to photon energies (Dong 2002), (Bower 
1998). However, one major drawback when using TLDs is their lack of real-time 
measurement capabilities. Furthermore, the dosimeters need to be replaced after 
every exposure (I, IV) making extensive studies more laborious, time consuming, 
and prone to error and imprecision (III). 
OSLD: Optically stimulated luminescent dosimeters have been used for effective 
dose assessment in tissue equivalent (ATOM) phantoms (Ludlow 2013). The major 
benefits of OSL dosimeters are their high sensitivity and ease of use. Nevertheless, 
similarly as in the case of the TLDs, the OSLDs have to be removed from the 
phantom for dose read-out and erasure procedures.
RPLD: Radio-photoluminescence dosimeters (RPLD) have also been used for 
therapeutic applications (Akselrod 2006) and effective dose evaluation with 
anthropomorphic phantoms (Manninen 2014a), (Manninen 2014b).
MOSFET: MOSFET dosimeters have been previously used in diagnostic radiology 
(Lian 2011), (Lian 2012), patient dosimetry Briere 2008), and entrance surface 
dose measurements in diagnostic radiology (Peet 1999). MOSFET dosimeters are 
manufactured using semiconductor fabrication process and were first described 
16
1 Introduction 
in 1959 by John Atalla and Dawon Kahng (Kahng 1963). Since then, MOSFET 
technology has been used in personal dosimetry (O’Connel 1998), (Sarrabayrouse 
2004) and medical applications (Price 2004), (Ramaseshan 2004), (Lavallee 2006), 
(Tarr 2004), (Kohno 2006) (Lee 2011), (Kim 2010a), (Kim 2010b), (Kim 2011b), 
(Miksys 2010).
The major benefits of MOSFET dosimeters are their real-time measuring 
capability and the possibility to perform multiple measurements without the need 
to repeatedly dismantle and reposition the phantom. However, the drawbacks of 
MOSFET dosimeters are their low sensitivity when compared with TLDs and their 
limited lifetime due to the accumulated dose. A further limitation of MOSFETs is 
their variation of angular sensitivity. When comparing MOSFETs to TLDs, it must 
be taken into consideration that their uncertainty is greater than 25% at doses less 
than 1.7 mGy. Therefore, MOSFETs are commonly used in radiotherapy where 
much higher doses are applied (Spezi 2012), (Kouno 2013) (Miracle 2009)
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2 AIMS AND STRUCTURE OF THE THESIS
The first aim was to characterize MOSFET dosimeter sensitivity, energy, dose, and 
angular dependencies to assess their suitability for low-dose CBCT measurements 
in anthropomorphic phantoms. 
A second aim was to validate a newly developed dose measurement setup 
for effective dose assessment in anthropomorphic phantoms using Monte Carlo 
simulations and TLD measurements. 
The third aim was to apply the newly developed measurement setup to assess 
the effective doses resulting from three CBCT and one MSCT device. 
The thesis is based on five original articles referred to in the text by their Roman 
numerals. 
ARTICLE I: 
Koivisto J, Wolff J, Kiljunen T, Schulze D Kortesniemi M. “Characterization of 
MOSFET dosimeters for low-dose measurements in maxillofacial anthropomorphic 
phantoms” J Appl Clin Med Phys. 2015 Jul 8;16(4):5433.
In this study, 20 MOSFET dosimeters were characterized for two CBCT photon 
energy ranges (34.2–50.8 keV, 41.2–61.1 keV), dose properties, and organ dose 
measurements using TLD dosimeters as a reference. In addition, MOSFET dosimeter 
uncertainty was assessed by repetitive measurements at different doses. 
ARTICLE II:
Koivisto J, Kiljunen T, Wolff J, Kortesniemi M. Characterization of MOSFET 
dosimeter angular dependence free-in-air and in soft tissue equivalent material 
for three-axes rotation. Journal of Radiation Research, 2013, 00, 1–7 doi: 
10.1093/jrr/rrt015
In the second article, the MOSFET angular sensitivity was investigated using 
dental photon energies and soft tissue equivalent backscatter material. 
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2 Aims and structure of the thesis
ARTICLE III:
Koivisto J, Kiljunen T, Tapiovaara M, Wolff J, Kortesniemi M. Assessment of 
radiation exposure in dental cone-beam computerized tomography with the use 
of metal-oxide semiconductor field-effect transistor (MOSFET) dosimeters and 
Monte Carlo simulations. 
Oral Surg Oral Med Oral Pathol Oral Radiol. 2012 Sep;114(3):393-400.
In the third study, a dose measurement setup was developed. The setup 
comprised 20 MOSFET dosimeters that were placed into allocated grid holes of 
an anthropomorphic RANDO phantom. The MOSFET dose measurement setup 
was validated using Monte Carlo simulations. 
ARTICLE IV:
Koivisto J, Schulze D, Wolff J, Rottke D. Effective dose assessment in the maxillofacial 
region using thermoluminescent (TLD) and metal-oxide semiconductor field-effect 
transistor (MOSFET) dosimeters; A comparative study. 
Dentomaxillofacial Radiology. 2014 43(8)
In the fourth study, the previously developed MOSFET dose measurement setup 
was validated using TLD dosimeters (IV) that were placed in an anthropomorphic 
head phantom. The dose measurements were performed using four typical CBCT 
head examination protocols. 
ARTICLE V:
Koivisto J, Järnstedt J, Dastidar P, Wolff J, Kortesniemi M.  The effect of supine, 
prone and oblique head positioning on the effective dose in Cone Beam CT 
technology. 
 
Oral Surg Oral Med Oral Pathol Oral Radiol. 2014 Sep;118(3):355-62. 
doi: 10.1016/j.oooo.2014.05.016. Epub 2014 Jun 14.
In the fifth article, the MOSFET dose measurement setup was used for organ and 
effective dose assessment resulting from supine, prone, and oblique phantom 
positions in three CBCT and one MSCT device. 
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3 MATERIALS AND METHODS 
3.1. DOSIMETERS 
3.1.1 MOSFET DOSIMETERS
MOSFET dosimeters (TN-1002RD-H) comprise an n-type semiconductor substrate 
that is isolated from the metal gate (G) by a very thin silicon oxide (SiO2) layer 
(Fig. 3.1.1A). Ionizing radiation causes the generation of electron-hole pairs in the 
SiO2 layer. Some of the holes near the Si-SiO2 interface become trapped causing 
a stable, negative shift (DVTH) for a predetermined drain (D) – source (S) current 
(IDS ) that is proportional to the radiation dose. Several investigators have reported 
the operating principles of the MOSFET dosimeter (Tarr 1998), (Soubra 1994), 
(Sarrabayrouse 1994). The TN-1002RD-H dosimeter used in this study comprised 
two MOSFETs with an active area of 0.04 mm3 that were fabricated on a silicon 
rectangle (a die) mounted on a flexible polyamide (PCB) cable and encapsulated 
with black 1.02 mm thick (II) epoxy resin (Fig. 3.1.1B) (G1 and G2 are metal gates 
(G), D1 and D2 are drains (D)).  
Fig. 3.1.1.   MOSFET dosimeter structure (A) and TN-1002RD-H dosimeter (B)
All absorbed doses were measured using a mobile MOSFET device TN-RD-70-W20 
(Best Medical Canada, Ottawa, Canada). The TN-RD-70-W20 MOSFET device 
comprises a TN-RD-38 wireless Bluetooth transceiver, four TN-RD-16 reader 
modules, twenty high-sensitivity TN-1002RD-H dosimeters, and TN-RD-75M 
software. In this thesis, the TN-RD-16 reader modules were operated using the 
high bias voltage (13.6 V) to obtain the highest (mV/mGy) sensitivity. A TN-RD-38 
Bluetooth transceiver was used for data communication between the TN-RD-16 
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3 Materials and methods 
reader modules and a PC. Four TN-RD-16 reader modules and their power supplies 
are shown in Fig. 3.1.2.
Fig. 3.1.2. Four MOSFET TN-RD-16 reader modules 
3.1.2. REFERENCE DOSIMETERS 
Prior to their use, all MOSFET dosimeters were characterized for their performance 
by comparing their results with those obtained using a calibrated ionization 
chamber dosimeter and a multi-purpose dosimeter. The dose area product (DAP) 
value required for the Monte Carlo simulation program (PCXMC)  was measured 
using a ionization chamber dose area product (DAP) dosimeter. Furthermore, TLD 
dosimeters were used for comparative dose point dose measurements in the head 
phantom and in the MOSFET validation process.
Ionization chamber dosimeter: MOSFET dosimeter energy, dose, dose rate, and 
accumulated dose dependency reference readings were attained using a RADCAL 
1015 dosimeter and a RADCAL 10X5-6 ionization chamber (IC) (Radcal Corporation, 
Monrovia, CA, USA). The sensitivity variation of the ionization chamber was less 
than ±1% in the 30–70 keV range. 
Multi-purpose detector: The MOSFET dosimeter uncertainty was evaluated using a 
Barracuda multi-purpose detector (MPD) (RTI Electronics AB, Mölndal, Sweden). 
The MPD is capable of measuring ranges between 0.1 µGy–1000 Gy and has less 
than ± 1% energy sensitivity variation between 50–90 kVp. 
Ionization chamber DAP-meter: The dose area product (DAP) values were measured 
using a KermaX-plus IDP 120–104 Hs meter (IBA Dosimetry GmbH, Germany). 
Prior to the MOSFET characterization measurements, the multi-purpose detector, 
the ionization chamber dosimeter, and the ionization chamber DAP dosimeter were 
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calibrated at the secondary standard dosimetry laboratory (SSDL) of the Finnish 
Radiation and Nuclear Safety Authority (STUK) that is traceable to primary standard 
dosimetry laboratory (PSDL). 
TLD 100: TLD dosimeters (TLD 100; Thermo Fisher Scientific, Waltham, MA) 
were used to compare their performance with MOSFETs in an anthropomorphic 
RANDO phantom. TLD dosimeters emit light that is proportional to the radiation 
dose when heated after the irradiation exposure (IAEA No. 457, 2007). The reset 
and annealing procedures of the TLDs were made in a microprocessor-controlled 
TLD oven (PTW, Freiburg, Germany). The TLD read-out sequence was performed in 
a Fimel LTMWin (Fimel, Fontenay-aux-Roses, France) device. TLD calibration and 
read-out procedures were performed according to a method previously described 
by Rottke et al. (Rottke 2013) with traceability to secondary standard dosimetry 
laboratory (SSDL, Freiburg, Germany). 
3.2. CHARACTERIZATION OF MOSFET DOSIMETERS 
MOSFET dosimeter characterization was performed to evaluate their feasibility 
for low-dose measurements in an anthropomorphic phantom using dental 
photon energies. The characterization procedure consisted of energy, dose, dose 
rate, accumulated dose, and angular dependency measurements. In addition, the 
MOSFET dosimeter combined uncertainties were assessed.
3.2.1. PHOTON ENERGY DEPENDENCY
Defining the energy dependency characteristics of a dosimetric system (Izewska 
2005) is important when dosimeters are used with different mean photon energy 
spectra.  Furthermore, when MOSFETs are used for organ dose measurements 
their energy response should be known because the mean photon energy is affected 
by the attenuation of different tissues. Ideally, MOSFET dosimeters should be 
characterized according to the radiation qualities close to those for which the dose 
measurements are needed (Buerman 2010). 
In previous studies by Peet et al., Dong et al., and Manninen et al. (Peet 1999), 
(Dong 2002), (Manninen 2014a), the MOSFET energy dependency was evaluated 
as a function of tube voltage. This method, however, does not take into account the 
energy spectra or the mean photon energy of the x-ray device that is affected by 
the tube voltage and filtration used.  In this study, however, the MOSFET energy 
sensitivity was evaluated as a function of the mean photon energy (keV) using two 
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different filter combinations and a range of tube voltages. This method was chosen 
to encompass the typical mean photon energies used in dental and maxillofacial 
diagnostic procedures.
In this thesis, the photon energy sensitivity measurements were performed 
using 20 MOSFET dosimeters that were attached to an in-house constructed 
carbon fiber frame. The MOSFET positions were carefully chosen as a linear array 
perpendicular to anode-cathode direction to minimize the heel effect in the anode-
cathode direction. The subgroups of ten dosimeters on both sides of the (RADCAL) 
10 x 5-6 ionization chamber (Fig. 3.2.1) were interchanged to compensate for possible 
variations in dose across the field.  The measurements were repeated 10 times and 
an average calibration coefficient (mV/mGy) was calculated. In order to include the 
backscatter radiation, a (15 cm x 15 cm x 10 cm thick) PMMA block was attached 
to a carbon fiber holder to simulate soft tissue interactions (IAEA No. 457, 2007). 
The PMMA block dimensions were chosen based on a study by Khan et al. (Khan 
2003) and were considered, therefore, to provide sufficient backscatter for the Cu 
HVLs (mm) used in this study (Table 1).
Fig. 3.2.1. MOSFET dosimeter energy dependency measurement set-up 
The energy dependency measurements were carried out using a Promax 3D 
CBCT device operated without gantry rotation and constant doses to minimize 
possible dose or angular dependency (Al 2.5 mm filter: 17.6 ± 0.2 mGy, Al 2.5 
mm + 0.5 Cu: 20.6 ± 0.4 mGy). The tube voltage range was 50 – 90 kVp with 5 
kVp increments. The differences in the doses were caused by the different mAs 
values in the experimental setup.
In this thesis, mean photon energies and HVLs were calculated using a computer 
program (Tapiovaara 2008a) that is based on the semi-empirical spectrum model 
described by Birch and Marshall (Birch 1979). The mean photon energies, HVLs 
and tube voltages (kVp) used are presented in Table 1. 
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Table 1.  The calculated mean photon energies and corresponding Cu HVL’s using 2.5 mm  
Al and 2.5 mm AL+0.5 mm Cu filter combinations 
Tube Al (2.5mm)   Al (2.5 mm) +Cu (0.5 mm)
Voltage Mean E HVL Mean E HVL
kV keV Cu (mm) Al (mm)   keV Cu (mm) Al (mm)
50 34.2 0.072 2.26 41.2 0.161 4.50
55 36.4 0.081 2.54 44.2 0.192 5.11
60 38.6 0.093 2.80 46.9 0.224 5.68
65 40.7 0.104 3.06 49.6 0.258 6.22
70 42.8 0.115 3.33 52.2 0.294 6.73
75 45.0 0.129 3.61 54.7 0.333 7.24
80 47.1 0.144 3.91 57.1 0.373 7.71
85 49.0 0.159 4.21 59.2 0.411 8.12
90 50.8 0.176 4.50  61.1 0.448 8.49
The MOSFET calibration coefficient (CC) was calculated using the MOSFET read-
out value (mV) that was subsequently divided by the dose (mGy) and simultaneously 
measured using an ionization chamber dosimeter (Brady 2012).  Each MOSFET 
calibration coefficient was calculated separately and since the sensitivity differences 
between the dosimeters were minimal, thus the average sensitivity result was 
reported.
3.2.2. DOSE, DOSE RATE, AND ACCUMULATED DOSE DEPENDENCIES 
Ideally, a dosimeter reading should be linearly proportional to the dosimetric 
quantity and be independent of the radiation dose rate used for the measurements 
(Izewska 2005). Furthermore, dosimeters should always be characterized for their 
sensitivity since their lifetime dose history affects their sensitivity.
In order to obtain dose, dose rate, and accumulated dose dependencies, 20 
MOSFET dosimeters were irradiated 10 times on the Promax 3D CBCT device 
(Planmeca Oy, Helsinki, Finland). All exposures were performed using 80 kVp 
with a 2.5 mm Al filter and 47.1 keV mean photon energy. To attain MOSFET dose 
dependency, the irradiation was performed using seven different mAs values (10, 
20, 40, 80, 160, 320, and 640 mAs) over a dose range from 0.24 to 17.5 mGy. The 
average dosimeter responses were calculated for each dosimeter and dose value. 
The dose rate dependency was evaluated using a constant dose of 16.4 mGy with 
five different dose rates (0.16, 0.32, 0.67, 1.34, and 2.70 mGy/s). The mean dose 
rate dependency was calculated for each dosimeter and dose rate. In order to assess 
the MOSFET dosimeter accumulated dose sensitivity, an energy dependency setup 
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was used (Fig. 3.2.1). The sensitivities of the 20 MOSFET dosimeters were measured 
after dismantling the dosimeters from the phantom at a 17.500 mV accumulated 
threshold voltage. The MOSFET sensitivity was calculated based on the two different 
threshold voltages: 8.300 mV (after the calibration procedure) and 17.500 mV (after 
dismantling the dosimeters from the phantom). 
3.2.3. ANGULAR DEPENDENCY 
The dosimeter response variation with the angle of incidence of radiation is known 
as the directional or angular dependency (Izewska 2005). When performing dose 
measurements on CBCT devices, it is necessary to take the angular sensitivity 
dependency of the dosimeters into account because the MOSFET dose response 
varies depending on the angle of incidence. The major cause of this phenomenon 
is the asymmetrical geometry of the dosimeter. 
 In this thesis, the angular dependency measurements were performed using 
a soft tissue equivalent PMMA phantom. All x-rays used for defining the angular 
dependencies were generated using a Promax 3D cone beam CT x-ray device using 
80 kV tube potential (HVL 7.7 mm Al), 100 mAs tube current exposure time product, 
and 2.5 mm Al + 0.5 mm Cu filtration. 
The mean and standard deviation (1SD) of the reference air kerma measured 
in a single exposure (one of the five repeated exposures in each angular step) with 
an ionization chamber was 6.9 ± 0.2 mGy. All CBCT exposures were performed 
using an operating mode that disables the gantry rotation of the CBCT device, and 
thereby offers a fixed and stationary x-ray source. MOSFET dosimeter sensitivities 
were normalized to a 0-degree reading of the corresponding axis of rotation. The 
definition for zero degree orientation of the dosimeter is shown in Fig. 3.2.2 for 
each axis of rotation. 
Fig. 3.2.2. Irradiation geometry description for the angular sensitivity dependency 
measurements of the MOSFET dosimeter with axial (a), normal-to-axial (b), and tangent-to-axial 
rotation (c) co-ordinate axes and rotation angles
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The angular dependency coefficients (Cψ, Cθ, Cφ) were determined as follows (II):
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Fig. 3.2.2. Irradiation geometry description for the angular sensitivity dependency 
measurements of the MOSFET dosimeter with axial (a), normal-to-axial (b), and 
tangent-to-axial rotation (c) co-ordinate axes and rotation angles 
The angular dependency coefficients (C, C, C) were determined as follows (II): 
C  D()D(),C 
D( )
D( ),C 
D( )
D( )      (1) 
where D(), D(), and D() are the average doses from five repeated exposures at 
rotation angles , and , and D() , D( )	and	D()  are the average doses over 
all angle orientations for each rotation axis, respectively. Each angular position was 
measured with five repeated exposures to verify reproducibility and improve 
reliability and to determine the standard deviation (1SD) for that angular position. 
Specifically, the relative standard deviation (1SD) was determined for each rotation 
axis and within each angular position, relative to the angle specific mean value. The 
comparative MOSFET mean sensitivities between the studied rotational axes were 
verified with separate measurements in continuous full rotation exposures using 
three MOSFET detectors that were interchanged between repeated exposures to 
exclude individual detector sensitivity variations. 
Measurements: The angular dependency measurements were performed using a 
fixed x-ray source and a rotating in-house constructed cylindrical acrylic phantom 
that was 80 mm in diameter. Dose measurements were performed in three-axes 
using three dosimeters placed in 2.5 mm holes. (Fig. 3.2.3.) The smallest possible 
(2.5 mm) drill hole size was chosen to minimize the air gap and the “hole effect” 
caused by non-attenuated direct radiation. The in-house constructed PMMA 
phantom was rotated 360 degrees with five-degree increments (i.e. 72 measured 
directions per rotation) using a mechanical support resting on ball bearings. A 
reference reading of every exposure was simultaneously attained using a RADCAL 
1015 dosimeter and a RADCAL 10X5-6 ionization chamber (Radcal Corporation, 
Monrovia, CA, USA). A separate dial ring for adjusting the rotation angle was 
attached to the lower part of the phantom (Fig. 3.2.3.). The alignment of the 
phantom was assessed with ±1º accuracy using three laser lines generated by the 
CBCT x-ray device. The PMMA phantom included a hole for the ionization 
chamber. The ionization chamber was fitted tightly into the hole to avoid any air-
gap between the PMMA and the dosimeter. The ionization chamber remained 
where D(ψ), D(θ), and D(φ) re the aver g  doses from five repeated exposures at 
rotation angles ψ, θ and φ, and 
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Fig. 3.2.2. Irradi tion geome ry des ripti n for the angular ensitivity depe dency 
measurements of the MOSFET dosimeter with axial (a), normal-to-axial (b), and 
tangent-to-axial rotation (c) co-ordinate axes and rotation angles 
The angular dependency coefficients (C, C, C) were determined as follows (II): 
C  D()D(),C 
D( )
D( ),C 
D( )
D( )      (1) 
where D(), D(), and D() are the avera e s from five repeated exposures at 
rotation angles , and , and D() , D( )	and	D()  are the average doses over 
all angle orientations for each rotation axis, respectively. Each angular position was 
measured with five repeated exposures to verify reproducibility and improve 
reliability and to determine the standard deviati n (1SD) f r that angular osition. 
Specifically, the relative standard deviation (1SD) was determined for each rotation 
axis and within each angular position, relative to the angle specific mean value. The 
comparative MOSFET mean sensitivities between the studied rotational axes were 
verified with separate measurements in con inuous full rotati n exposures using 
three MOSFET detectors that were interchanged between repeated exposures to 
exclude individual detector sensitivity variations. 
Measurements: The angular dependency measurements were performed using a 
fixed x-ray source and a rotating in-house constructed cylindrical acrylic phantom 
that was 80 mm in diameter. Dose measurements were performed in three-axes 
using three dosimeters placed in 2.5 mm holes. (Fig. 3.2.3.) The smallest possible 
(2.5 mm) drill hole size was chosen to minimize the air gap and the “hole effect” 
caused by non-attenuated direct radiation. The in-house constructed PMMA 
phantom was rotated 360 degrees with five-degree increments (i.e. 72 measured 
directions per rotation) using a mechanical support resting on ball bearings. A 
reference reading of every exposure was simultaneously attained using a RADCAL 
1015 dosimeter and a RADCAL 10X5-6 ionization chamber (Radcal Corporation, 
Monrovia, CA, USA). A s par te ial ring for djusting the rotation angle was 
attached to the lower part of the phantom (Fig. 3.2.3.). The alignment of the 
phantom was assessed with ±1º accuracy using three laser lines generated by the 
CBCT x-ray device. The PMMA phantom included a hole for the ionization 
chambe . Th  ionization chamber was fitted tightly into the hole to avoid any air-
gap between the PMMA and the dosimeter. The ionization chamber remained 
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Fig. 3.2.2. Irradiation geometry description for the angular se s tivity dependency 
measurements of the MOSFET dosimeter with axial (a), normal-to-axial (b), and 
tangent-to-axial rotation (c) co-ordinate axes and rotation angles 
The angular dependency coefficients (C, C, C) were determined as follows (II): 
C  D()D(),C 
D( )
D( ),C 
D( )
D( )      (1) 
where D(), D(), and D() are the average doses fro fi  r ted exposur s at 
r tation angles , and , and D() , D( )	 	D()  are the average doses over 
all angle orientations for each rotation axis, respectively. Each angular pos tion was 
measured with five repeated exposures to verify reproducib lity and improve 
reliab lity and to determin  the standar  d viation (1SD) for that angular p s tion. 
Specifically, the relative standard deviation (1SD) was determined for each rotation 
axis and within each angular pos tion, relative to the angle specific mean value. The 
comparative MOSFET mean sens tiv ties betw en the studied rotational axes were 
verified with separate measurements in continuous full rotation xposur s using 
thr e MOSFET detectors that were interchanged betw en repeated exposures to 
exclude individual detector sens tivity variations. 
Measurements: The angular dependency measurements were performed using a 
fixed x-ray source and a rotating in-house constructed cylindrical acrylic phantom 
that was 80 mm in diameter. Dose measurements were performed in thr e-axes 
using thr e dosimeters placed in 2.5 mm holes. (Fig. 3.2.3.) The smallest po sible 
(2.5 mm) drill hole size was chosen to minimize the air gap and the “hole effect” 
caused by non-attenuated direct radiation. The in-house constructed PMMA 
phantom was rotated 360 degr es with five-degr e increments (i.e. 72 measured 
directions per rotation) using a mechanical su port resting on ball bearings. A 
reference reading of every exposure was simultaneously attained using a RADCAL 
1015 dosimeter and a RADCAL 10X5-6 ionization chamber (Radcal Corporation, 
Monrovia, CA, USA). A separate dial ing fo  adjusting the rotation angle was 
attached to the lower part of the phantom (Fig. 3.2.3.). The alignment of the 
phantom was a se sed with ±1º a curacy using thr e laser lines generated by the 
CBCT x-ray device. The PMMA phantom included a hole for the ionization 
chamber. The ionization chamber was fitted tightly into the hole t  avoid any air-
gap betw en the PMMA and the dosimeter. The ionization chamber remained 
 verage doses over 
all angle orienta ions for  r i n axis, r spectively. Each ngular position 
was s red ith fi  r ted osures to verify r roducibility and improve 
reliability and to determine the standard deviation (1SD) for that angular position. 
Specifically, the rel tive standard deviation (1SD) was determined for each r tation 
axis and within each angular position, relative to the angle specific mean value. The 
comparative MOSFET mean sensitivities between the studied rotational axes were 
verified with separate measurements in continuous full rotation exposures using 
thre  MOSFET etectors that were nte cha ged between repeated exposures to 
exclude individual detector sensitivity variations.
Measurements: The angular dependency measurements were performed using a 
fixed x-ray source and a rotating i -house constructed cylindrical acrylic hantom 
that was 80 mm in diam ter. D  measure n s were erform d in thre -axes 
using three dosimeters placed in 2.5 mm holes. (Fig. 3.2.3.) The smallest possible 
(2.5 mm) drill hole size was chosen to minimize the air gap and the “hole effect” 
caused by non-attenuated di ect radiation. The in-house constructed PMMA 
phantom was rotated 360 degrees ith five-degree increments (i.e. 72 measured 
directions per rotation) using a mechanical support resting on ball bearings. A 
referen e reading of every exp sur  was simultaneously attain d usi g a RADCAL 
1015 dosi eter and a RADCAL 0X5-6 ionization chamber (Radcal Corpora ion, 
Monrovia, CA, USA). A separate dial ri g for adjusting the rotation a gle was 
attached to the lower part of the phantom (Fig. 3.2.3.). The alignment of the phantom 
was assessed with ±1º accuracy using three laser lines generated by the CBCT 
x-ray device. The PMMA phantom included a hole for the ionization chamber. The 
ionization amber was fitted tightly int  the ole to avoid any air-gap between the 
PMMA and the dosimeter. The ionization chamber remained stationary during the 
measurements while the PMMA cylinder and MOSFET dosimeters were rotated 
around the axis that was perpendicular to the anode-cathode axis to eliminate 
variations in irradiation caused by the heel effect (Fig. 3.2.3.).
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Fig. 3.2.2. Irradiation geometry description f r the angular sensitivity dependency 
measurements of the MOSFET dosimeter with axial (a), normal-to-axial (b), and 
tangent-to-axial rotati n (c) co-ordinate axes and rotati n angles 
The angular dependency coefficients ( , , ) were determined as follows (II): 
C  D()D(),C 
D( )
D( ),C 
D( )
D( )      (1) 
where D(), D(), and D() are the average doses from five repeated exposures at 
rotati n angles , and , and D() , D( )	and	D()  are the average doses over 
all angl  orientat ons for ach rotati n ax s, spect vel . Each angular positi n was 
measured with five repeated exposures to verify reproducib l ty and improve 
r liability and to determine the standard deviation (1SD) for that angular positi n. 
Specifically, the relative standard deviation (1SD) was determined for each rotati n 
axis an  it in e ch ang lar po iti n, relative to the angle pecific mean value. The 
comparative MOSFET mean se sitivities between the studied rotati nal axes were 
verified with separate measurements in continuous f ll rotati n exposures using 
three MOSFET detectors that were interchanged between repeated exposures to 
exclude i divi ual detector sensitivity ariatio s. 
Measurements: The angular dependency measurements were performed using a 
fixed -ra  s urc  and a rotating i -hous constru ted cylindrical acrylic phantom 
that was 80 mm in diamet r. Dose m asurements were performed in three-axes 
using three dosimeters placed in 2.5 mm holes. (Fig. 3.2.3.) The smallest possible 
(2.5 mm) drill hole size was chosen to mi i iz  the air ga  nd the “ ole effect” 
caused by non-attenuated direct radiation. The in-house constructed PMMA 
phantom was rotated 360 degrees with five-degree increments (i.e. 72 measured 
directions per rotati n) using a mechanical support resting on ball bearings. A 
referenc readi g of every xposur  was simul ane usly ttai ed using a RADCAL 
1015 dosimeter and a RADCAL 10X5-6 ionization cham er (Radcal Corporati n, 
Monrovia, CA, USA).  separat  dial ring for adjusting the otati n angle was 
attached to the lower part of the phantom (Fig. 3.2.3.). The alignme t of the 
phantom was assessed with ±1º accuracy using three laser lines generated by the 
CBCT x-ray device. The PMMA phantom included a hole for the ionization 
chamber. The ionization chamber was fitted tightly into the hole t  av id any air-
gap between the PMMA and the dosimeter. The ionization chamber remained 
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Fig. 3.2.3. The rotation mechanism, MOSFET dosimeters, ionization chamber (RADCAL 10X5-6), 
and PMMA backscatter material
3.2.4. MOSFET DOSIMETER UNCERTAINTY 
Uncertainty is an interval about the average value of a series of measurements 
or calculations that, within a certain level of confidence, is believed to contain 
the “true” value of quantity (Mitch 2009). In this thesis, the MOSFET dosimeter 
uncertainty was assessed according to the UK National Dose protocol (NRPB, 
1992), where the maximum patient dose uncertainty has been proposed to be 25% 
at 95% confidence interval (CI). In order to evaluate the uncertainty, all MOSFET 
and multi-purpose dosimeters (MPD) were simultaneously exposed to 80 kVp (47.1 
keV, HVL 7.71 mm Al, SID 600 mm) using a Promax 3D CBCT device (Planmeca 
Oy, Helsinki, Finland) with a 2.5 mm Al filter. The x-ray source was operated 
without gantry rotation using seven mAs values (10, 20, 40, 80, 160, 320, and 
640 mAs). The corresponding doses were as follows: 0.24, 0.52, 1.1, 2.2 4.4, 8.8, 
and 17.6 mGy, respectively.
The MPD dosimeter calibration coefficient (1.018) for 80 kVp tube voltage 
(2.5 mm Al + 0.5 mm Cu) was used to convert the dosimeter reading to the true dose. 
The calculated expanded uncertainty (2SD) of the MPD using 10 averaged samples 
was 1.1%. The combined uncertainty (uc) was calculated as a quadratic summation of 
the uncertainties of MPD and MOSFET readout uncertainties (k=2). Furthermore, 
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the lowest acceptable dose using one exposure and the required number of samples 
to attain low dose limit (0.3 mGy) were assessed.
The combined uncertainties (uc) of the photon energy sensitivity measurements 
were assessed as a weighted sum of variances. These included the ionization chamber 
expanded (2SD) energy sensitivity uncertainty 2% (30–70 keV) obtained from the 
RADCAL 1015 datasheet, MOSFET dosimeter calibration factor variation as a 
function of saturation voltage (4%) (I) (Koivisto 2014), and the estimated position 
uncertainty (2%) and cable irradiation uncertainties (1%) according Ehringfelt et 
al. (Ehringfeld 2005).
3.3.  HEAD PHANTOM USED FOR EFFECTIVE  
 DOSE ASSESSMENT
In order to define the effective doses in the maxillofacial region, an anthropomorphic 
radiation analogue dosimeter (RANDO) phantom was used. All measurements in 
this thesis were performed using a RANDO RAN102 male head phantom (Radiation 
Analogue Dosimetry System; The Phantom Laboratory, Greenwich, NY, USA). The 
phantom comprised a human skull cast in a soft-tissue-equivalent material to match 
the attenuation and scattering conditions of the bone, soft tissues, and airways of 
the human head. The phantom was composed of ten 25 mm thick layers numbered 
in order from 0 to 9 from the calvaria to the neck area (Fig. 3.3.1.). Each layer 
had a grid of holes (ø 5 mm) filled with detachable soft-tissue equivalent plugs for 
dosimeter placement.  
In order to measure the absorbed doses of the most radiosensitive organs, twenty 
MOSFET and 40 TLD dosimeters were positioned into different layers of the RANDO 
head phantom. The twenty MOSFET dosimeters were positioned into the phantom 
head layers (Fig. 3.3.1.) according to a protocol described by Ludlow et al. (Ludlow 
2006). However, in this study, the dosimeters in the calvarium posterior, calvarium 
left, left lens, and left orbit were not included. The reason that only 20 dosimeters 
were used in the present study was based on the assumption that the organ dose 
in the brain area is relatively low and that the dose in the left eye and the left orbit 
would be the same as that of the right side in symmetric imaging geometry (III).
All dosimeters were placed in allocated grid holes with their epoxy bulbs facing 
in the anterior direction in order to assess the gantry rotation sensitivity variations 
of the scans. In addition, the MOSFET cables were routed from the phantom skull 
base through the prefabricated airway compartments and the unused dosimeters 
voids to the designated layers. The phantom layers were then stacked on top of 
each other to avoid any gaps between them. The placement of the dosimeters with 
the corresponding layers in the phantom is presented in Fig. 3.3.1.
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Fig. 3.3.1. MOSFET dosimeter placement in RANDO phantom
3.4 EQUIVALENT AND EFFECTIVE DOSE ASSESSMENT
Equivalent dose (HT) and effective dose (E) are defined as radiation protection 
quantities (Suomalainen 2010). Equivalent dose is a quantity that is used for the 
comparison of different radiation types. Equivalent dose is calculated based on the 
absorbed dose and furthermore takes the biological effectiveness of the radiation 
into account. Effective dose quantity allows a comparison of the stochastic risks 
induced by different imaging protocols, i.e. x-ray sources. Effective dose (Sievert, 
(Sv)) is calculated according to the recommendations set by the International 
Commission on Radiological Protection (ICRP). Effective dose calculation is 
performed by multiplying the organ doses by their weighting factors based on the 
radiation sensitivity of each organ. 
In this thesis, the equivalent dose or radiation-weighted dose HT for all organs 
or tissues T was calculated using the following equation (Pauwels 2010), (Loubele 
2009) (III), (IV), (V): 
                       
  
HT = wR fi
i
∑ ⋅ DTi       (2)
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where the radiation weighing factor wR = 1 (Sv/Gy) for x-rays, fi the mass fraction 
of tissue T in layer i, and DTi being the average absorbed dose of tissue T in layer i. 
Summation is done for all phantom layers between 0 and 9. The dosimeter locations 
chosen in this study represent the most radiosensitive organs in the maxillofacial and 
neck area. The fraction in the head and neck area (Σ(fi)) of most organs including 
the thyroid gland, brain, salivary glands, extrathoracic airways, and oral mucosa 
is 1. This is because these organs are located within the RANDO phantom layers. 
It has been estimated that the proportion of lymphatic nodes and muscle in the 
head and neck area represent 5% of the total body mass. According to Ludlow et 
al. (Ludlow 2003), the fraction of irradiation in the esophagus is 10% and the skin 
surface area in the head and neck area is 5% of the total body skin area. 
The effective dose was obtained from measured organ doses using the revised 
guidelines given by the International Commission on Radiological Protection (ICRP 
103, 2008). The effective dose E is calculated by the following equation (III), (IV), (V):
  
  
E = wT
T
∑ ⋅ HT ,       (3)
where wT is the weighting factor of tissue T and HT is the equivalent dose in tissue 
T. According to the ICRP recommendation, the calculation of effective dose is based 
on a large number of organs and tissues in the body and the sum of their weighting 
factors wT is 1. Some of the organs considered in the calculation are grouped as 
“remainder tissues”. The wT for the remainder tissues specified by ICRP 103 is 0.12.
The equivalent dose in bone marrow and the bone surface was calculated by 
averaging the equivalent doses of the corresponding dosimeters representing the 
organ. Finally, the contribution to the effective dose was calculated using specific 
fractions irradiated and weighting factors. The ICRP 103 weighting factors wT and 
the fraction of irradiation used in the calculations are shown in Table 2.
Since bone has a higher mass energy absorption coefficient than soft tissue, the 
bone surface dose was obtained by multiplying the bone marrow dose with the mass 
energy absorption coefficient ratio of bone and soft tissue at the average photon 
energy. In this thesis, the average energy was calculated using a computer program 
(Tapiovaara 2008a) that is based on the semi-empirical spectrum model described 
by Birch and Marshall (Birch 1979). The calculated average energy of the spectrum 
is 58.8 keV, and the ratio of the mass energy absorption ratios of bone and soft 
tissue (NBS Handbook No. 85 1964) is 3.23. This value was used to multiply the 
bone marrow doses to obtain the bone surface doses.
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Table 2  ICRP 103 tissue weighting factors (wT), fractions irradiated (fi), and  
the dosimeters used to calculate the effective dose (III).
fi 
Dosimeter
numberTissue wT
Thyroid 0.04 1 18, 19
Esophagus 0.04 0.1 20
Brain 0.01 1 2, 3
Skin 0.01 0.05 5, 6, 12
Salivary glands 0.01 1
Parotid 9, 10
Submandibular 15, 16
Sublingual 17
Bone marrow 0.12 0.165
Mandible 0.013 7, 8, 13, 14
Calvaria 0.118 1, 4
Cervical spine 0.034 15
Bone surface* 0.01 0.165
Mandible 0.013 7, 8, 13, 14
Calvaria 0.118 1, 4
Cervical spine 0.034 15
Remainder 0.12   
Lymphatic nodes 0.05 9, 10, 15–17
Extrathoracic airway 1 4, 11, 18, 20
Muscle 0.05 9, 10, 15–17
  Oral mucosa  1 7–10, 13–17
*Bone surface dose = bone marrow dose x 3.23.
3.5. MOSFET SETUP USED FOR EFFECTIVE DOSE ASSESSMENT
The effective dose assessment setup consisted of an anthropomorphic RANDO 
phantom, MOSFET dosimeters, MOSFET dosimeter readers, and corresponding 
power supplies. All MOSFET dosimeters were placed into allocated organ positions 
in the phantom.  The RANDO phantom head was attached to a carbon fiber 
mechanism supported by a camera holder to allow the phantom to be tilted in 
different directions (Fig. 3.5.1). 
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Fig. 3.5.1 The MOSFET measurement setup with four TN-RD-16 reader modules, RANDO phantom, 
and a ProMax 3D MID CBCT device (I).
3.6. VALIDATION OF THE MOSFET DOSE  
 MEASUREMENT METHOD
In the validation process, the MOSFET measurement setup was evaluated for its 
suitability for effective dose assessments using typical dental exposures. Validation 
was performed using two different methods that were based on simulations and 
comparative dose measurements using TLD dosimeters in identical conditions.
3.6.1. EFFECTIVE DOSES DETERMINED USING MOSFETS AND  
 MONTE CARLO SIMULATIONS
PCXMC (Radiation and Nuclear Safety Authority, Helsinki, Finland) (Tapiovaara 
2008b) is a widely used Monte Carlo-based simulation program for calculating 
absorbed organ doses and effective doses in x-ray examinations based on measurable 
quantities, e.g. dose area product (DAP) or incident air kerma (ICRU 74, 2005). 
Monte Carlo calculations are based on the stochastic mathematical simulation 
of interactions between photons and matter. Photons are emitted (in a fictitious 
mathematical sense) from a point source into the solid angle specified by the focal 
distance and the x-ray field dimensions. The photons are then followed while they 
randomly interact with the phantom according to the probability distributions of 
the physical processes that they may undergo: photo-electric absorption, coherent 
(Rayleigh) scattering or incoherent (Compton) scattering (Tapiovaara 2008b). 
In PCXMC, organ doses and the effective dose are calculated using a modified 
anatomical phantom based on a mathematical hermaphrodite phantom model 
described by Cristy and Eckerman (Cristy 1987). When calculating the effective dose, 
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the tissue weighting factors of both the International Commission on Radiological 
Protection (ICRP) Publication 103 (ICRP 103,2008) and Publication 60 (ICRP 60, 
1990) are used. The latest PCXMC software version (2.0) allows multiple projection 
simulations in batch mode and has been used for non-dental CBCT examinations 
(Vassileva 2010), (Podnieks 2012), (He 2010).
MOSFET dose measurements: In order to evaluate the variations in effective dose 
caused by phantom movement, the organ doses were measured by directing the cone 
beam to 39 different vertical positions using 0.5 cm increments. The measurements 
covered layers 2 – 8 (from the calvaria to the thyroid gland) on the RANDO phantom 
(Fig. 3.6.1). The exposed phantom layers correspond roughly to Zref values of 76 – 
97.5 cm on the MC simulations (Fig. 3.6.2). Ten exposures were performed for each 
position using 8 x 8 cm field of view (FOV) and standard clinical scan parameters 
(84 kV, 12 mA, 145 mAs). The absorbed organ doses of ten measurements were 
averaged and used to calculate effective doses for each vertical position, respectively.
Figure 3.6.1. RANDO phantom head with superimposed PCXMC coordinates (Z) and  
a variable x-ray beam centerline
Monte Carlo simulations: PCXMC is a Monte Carlo simulation program used to 
calculate the organ doses of patients in x-ray examinations. The program calculates 
the organ doses in 29 organs and the effective dose using weighting factors according 
to ICRP publication 103 (ICRP 103, 2008).  In the PCXMC simulation program, 
the coordinate system has its location of origin in the middle of the base of the 
trunk of the phantom. The positive Z-axis points upwards, the x-axis to the left 
hand side, and the y-axis to the back of the phantom. The angles of incidence and 
a reference point (Xref, Yref, Zref) specify the x-ray beam centerline through which 
the central axis of the x-ray beam is directed. The simulations in this thesis were 
made for the PCXMC model beam centerline Zref coordinates between 71 cm and 
93 cm. The rotation axis of the simulations was set to Yref of -5 cm to cover the oral 
cavity volume. The organ doses and effective doses based on the simulations are 
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later presented as a function of the x-ray beam height position coordinate Zref. The 
head and neck area of the PCXMC phantom with some organs, the focal point, and 
z- coordinates (cm) are presented in Fig. 3.6.2.
Figure 3.6.2. The PCXMC phantom model showing the neck and head area, t 
he focal point and z- coordinates
Effective and absorbed dose simulations were performed using an 8 x 8 cm field of 
view (FOV). The dose normalization was based on the measured DAP values from the 
CBCT exposures. The DAP values were measured ten times using standard clinical 
scan parameters (84 kV, 12 mA, 145 mAs) and a KermaX-plus IDP 120–104 Hs meter 
(IBA Dosimetry GmbH, Germany). The average DAP value was 574 mGy.cm2. The 
simulations were made based on the uniform angular output of the CBCT system 
and covering a rotation angle range of 200 degrees with two-degree graduation 
in 101 steps: the DAP value for each individual projection of the simulation was 
5.68 mGycm2. The simulations included organ doses for all tissues and organs 
specified by the ICRP dosimetry formalism such as active bone marrow, thyroid 
gland, esophagus, skin, salivary glands, and brain. 
3.6.2. MOSFET AND TLD COMPARISONS
The feasibility of the MOSFET dosimeters in effective dose assessment was 
validated by comparing their performance with those of TLD dosimeters in an 
anthropomorphic head phantom using four different CBCT head examination 
protocols (Table 3.). Consecutive measurements were performed using 40 TLD 
and 20 MOSFET dosimeters that were alternately placed in 20 designated sites 
in the RANDO phantom (Figure 3.3.1.). The chosen locations represented the 
most radiosensitive organs in the maxillofacial region. All TLD and MOSFET 
measurements were repeated 10 times to improve the overall statistical outcome.
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Table 3. Exposure parameters of measured protocols (IV)   
Protocol name
Face
Maxillofacial
Teeth 
Upper jaw
Tooth
Mandible
Teeth
Both jaws
  Low dose Low dose Low dose Std. Dose
Protocol no. 1 2 3 4
Tube voltage (kVp) 90 90 90 90
Tube current (mA) 6 4 4 10
Exposure time (s) 18 2.8 2.5 12
Q (mAs) 108 11.4 15.1 121
Voxel edge length (mm) 0.6 x 0.6 0.4 x 0.4 0.4 x 0.4 0.2 x 0.2
Frame number 300 300 300 300
Scan FOV (cm) 20 x 17 8.5 x 5 4 x 5 10 x 10
In order to ensure the reproducibility of the phantom position and to minimize 
phantom shift or rotation (Ludlow 2009), the RANDO phantom holder was tightly 
fixed to the CBCT chin support. The acquisition FOVs were controlled using a 
scout image acquired prior to the actual CBCT exposures. The investigated FOVs 
are presented in Fig. 3.6.3.
Fig. 3.6.3. Image demonstrating the default CBCT (Promax 3D MID) FOVs used in the study (A) Face (20 
x 17),  (B) Teeth Upper Jaw (8.5 x 5), (C) Tooth Mandible (4 x 5), (D) Teeth Both Jaws (10 x 10) 
In order to obtain absorbed organ doses (mGy), the MOSFET dosimeter readings 
(mV) were multiplied with the corresponding calibration coefficients (mGy/mV) 
using the TN-RD-75M software. The comparative effective doses were assessed 
using two TLD dosimeters at each of the 20 designated sites. The TLD read-out 
was subsequently multiplied with the calibration factor, averaged, and subtracted 
by the background radiation according to a previous study by Rottke et al. (Rottke 
2013). The effective doses were obtained from the measured organ doses using the 
revised guidelines given by the ICRP publication 103 (ICRP 103, 2008).
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3.7.  MOSFET DOSE MEASUREMENT SETUP APPLICATION
In this thesis, the MOSFET setup was used for organ and effective dose 
assessments resulting from supine, prone, and oblique phantom positions in 
the maxillofacial region using a novel cone beam computed tomography (CBCT) 
device and from two conventional dental CBCTs and one multi-slice computed 
tomography (MSCT) device.
In order to investigate the impact of the CBCT partial (210º) gantry scan on the 
effective dose in the maxillofacial region, the exposures were performed using a 
Planmed Verity CBCT device (Planmed Oy, Helsinki, Finland) that allowed imaging 
in supine, prone, and oblique phantom positions (V).
The effective dose attained in different phantom positions and the results 
acquired using two dental CBCT scanners and an MSCT device using standard 
protocols were compared. Furthermore, effective dose reference values were 
obtained using a Promax 3D MAX (Planmeca Oy, Helsinki, Finland), an i-CAT 
Next Generation (Imaging Sciences International, Hatfield, PA, USA), and a Philips 
Brilliance-64, (64 slice) (Philips Medical Systems, Eindhoven, Netherlands). The 
Promax 3D MAX was operated using equivalent exposure parameters (kV, mAs) in 
a high-resolution mode (face 13 cm), the i-CAT Next Generation was operated in a 
high-resolution mode (landscape 13 cm), and the MSCT scanner was operated using 
the manufacturer-recommended, high-resolution imaging protocol. The exposure 
parameters used for the measurements are presented in Table 4. 
Table 4. Exposure parameters used on the MSCT and CBCT scanners (V)  
 
Planmed
Verity
CBCT
Promax
3D MAX
CBCT
i-Cat
Next Gen.
CBCT
Philips
Brilliance 64
MSCT
Tube voltage (kVp) 96 96 120 120
Tube curr. (mA) 9.5 5 5 93
Exp. Time (s) 6 12 7.4 0.912
Q (mAs) 57 60 37.1 85
Slice thickness (mm) 0.2 0.2 0.25 0.67
Slice increment (mm) 0.2 0.2 0.25 0.33
Pitch (mm) na na na 0.55
CTDIvol (mGy) na na na 11
Voxel (mm) 0.2 x 0.2 x 0.2 0.2 x 0.2 x 0.2 0.25 x 0.25 x 0.25 0.33x0.352x0.352
Scan angle 210º 210º 360º 360º
Pulsed yes yes yes -
Frame number 300 300 300 -
Scan FOV (cm) 13x16 13x13 13x16 16x18
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Phantom positions
Three default patient positions (supine, prone, and oblique) were investigated using 
a phantom and a Planmed Verity CBCT scanner. In the supine imaging position, 
the gantry, including the x-ray source and detector, rotates at a 210º angle from 
the anterior side. In the prone imaging position, the detector rotates from the 
posterior side of the phantom. In the oblique imaging (seated patient) position, 
the x-ray tube rotates from the cranium side of the phantom. Measurements using 
dedicated dental CBCTs were performed in the default (prone) position using 210º 
partial scan (Promax 3D MAX) and 360º full scan (i-CAT Next Generation). MSCT 
dose measurements were performed using a full 360º scan in (typical clinical) 
supine (lying patient) position. Philips Brilliance-64 and i-Cat effective doses were 
obtained in only one position. This was because 360º gantry rotation provides a 
symmetric dose profile in MSCT and CBCT devices and thus results in an equivalent 
dose distribution in all positions. The positioning of the acquisition volume in 
each case was assessed using a scout image acquired prior to the actual MSCT 
and CBCT exposures.
3.8. EFFECTIVE DOSE UNCERTAINTIES 
The absorbed and effective dose uncertainties were evaluated based similarly on 
a previous study by Koivisto et al. (Koivisto 2013). The point dose measurement 
uncertainty was calculated as the weighted sum of variances and included the 
statistical measurement variations. The results were as follows: dosimeter and 
phantom positioning uncertainties (10%, 10%) (III), angular dependency variation 
(5%) (II), accumulated dose variation (4%) (I), x-ray source variation (5%) (IV), 
and cable irradiation uncertainties (1%) (Ehringfeld 2005). 
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4 RESULTS 
4.1. CHARACTERIZATION OF MOSFET DOSIMETERS
4.1.1. PHOTON ENERGY DEPENDENCY
The MOSFET sensitivity measured using different filtrations was 3.10 ± 
0.10 mV/mGy and 3.08 ± 0.14 mV/mGy using 2.5 mm Al and 2.5 mmAl+0.5 Cu 
filter combinations, respectively. The photon energy sensitivities (mV/mGy) and 
relative energy sensitivities using 2.5 mm Al filter and 2.5 mm Al + 0.5 mm Cu 
filter combinations with standard deviation (1SD) are presented in Fig. 4.1.1 and 
Fig. 4.1.2. The MOSFET dosimeter sensitivity was not statistically dependent on 
the chosen kVp or the filtration according to two-tailed Student’s T-test (p = 0.75) 
and Pearsons correlation (pAl = 0.81, pAl+Cu = 0.17).
Fig. 4.1.1. MOSFET dosimeter sensitivity (mV/mGy) using a 2.5 mm Al filter (A)  
with corresponding error bars (1SD), (y=0.0001 + 3.0882, R2=0.00902).
38
4 Results 
Fig. 4.1.2. MOSFET dosimeter sensitivity (mV/mGy) using a 2.5 mm Al + 0.5 mm Cu filter (B) 
with corresponding error bars (1SD), (y=-0.024x + 3.2506, R2=0.25435).
4.1.2. DOSE, DOSE RATE, AND ACCUMULATED DOSE DEPENDENCIES 
The MOSFET dosimeter dose dependency was insignificant with the following 
linear regression: y=1.0030x + 0.0396. The MOSFET dosimeters showed a good 
correlation with the MPD reference dosimeter (R2= 0.99987). The standard 
deviation of the dose dependency measurements ranged from 2.4% to 12.5 %. 
The MOSFET dosimeter dose rate sensitivity was 3.14 ± 0.11 mV/mGy for all 
evaluated dose rates (0.16 – 2.70 mGy/s).  At 8.300 mV, the accumulated threshold 
voltage accumulated dose dependency was 3.10 ± 0.10 mV/mGy. At 17.500 mV, 
the accumulated threshold voltage calibration resulted in 2.83 ± 0.12mV/mGy 
sensitivity. The average sensitivity decrease was 9.4 % over 9200 mV threshold 
voltage variation. The MOSFET sensitivity decrease rate caused by the accumulated 
dose was 1.02% per 1000 mV.
4.1.3. ANGULAR DEPENDENCY 
The mean value and standard deviation of the measured sensitivity evaluated for 
PMMA for each rotation axis are presented in Table 5. The PMMA axial rotation 
measurements demonstrated a 5% standard deviation from the mean value (II). 
Table 5. The mean and standard deviation of the measured sensitivity in PMMA
Material
Axial
rot.(Ψ)
(mV/mGy)
Normal to
axial rot.(θ)
(mV/mGy)
Tangent to
axial rot.(φ)
(mV/mGy)
PMMA 3.1 ± 0.1 3.3 ± 0.2 3.4 ± 0.2
Fig. 4.1.2
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4.1.4. MOSFET DOSIMETER UNCERTAINTY 
The type A standard uncertainty (Err(D)) was assessed for six dose levels. The 
uncertainties of the ten repeated measurements were evaluated for each dose using 
95% confidence interval (CI) (k=2). The combined uncertainty at 95% confidence 
interval at different doses were fitted into an exponential function and resulted in 
the following equation:
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The MOSFET dosimeter dose dependency was insignificant with the following 
linear regression: y=1.0030x + 0.0396. The MOSFET dosimeters showed a good 
correlation with the MPD reference dosimeter (R2= 0.99987). The standard 
deviation of the dose dependency measurements ranged from 2.4% to 12.5 %. The 
MOSFET dosimeter dose rate sensitivity was 3.14 ± 0.11 mV/mGy for all 
evaluated dose rates (0.16 – 2.70 mGy/s).  At 8.300 mV, the accumulated 
threshold voltage accumulated dose dependency was 3.10 ± 0.10 mV/mGy. At 
17.500 mV, the accumulated threshold voltage calibration resulted in 2.83 ± 
0.12mV/mGy sensitivity. The average sensitivity decrease was 9.4 % over 9200 
mV threshold voltage variation. The MOSFET sensitivity decrease rate caused by 
the accumulated dose was 1.02% per 1000 mV. 
4.1.3. Angular dependency
The mean value and standard deviation of the measured sensitivity evaluated for 
PMMA for each rotation axis are presented in Table 5. The PMMA axial rotation 
measurements demonstrated a 5% standard deviation from the mean value (II).  
Table 5. The mean and standard deviation of the measured sensitivity in PMMA 
Axial Normal to Tangent to 
rot.() axial rot.() axial rot.() 
Material (mV/mGy) (mV/mGy) (mV/mGy) 
PMMA 3.1 ± 0.1 3.3 ± 0.2 3.4 ± 0.2 
 
4.1.4. MOSFET dosimeter uncertainty
The type A standard uncertainty (Err(D)) was assessed for six dose levels. The 
uncertainties of the ten repeated measurements were evaluated for each dose using 
95% confidence interval (CI) (k=2). The combined uncertainty at 95% confidence 
interval at different doses were fitted into an exponential function and resulted in 
the following equation: 
 Err(D)  (0.285* D0.692 0.052)*n0.5 ,		 	 (4) 
where D is dose in (mGy) and n is the number of samples (exposures). The 
coefficient of determination was R2 = 0.99. The single sample (n = 1) low dose limit 
for the MOSFET dosimeter was 1.7 mGy (Fig. 4.1.3). Furthermore,	 solving	
equation	(4)	for	the	number	of	samples	(n)	and	the	setting	dose	(D)	to	the	TLD	
low‐dose	 limit	 (0.3	mGy),	 according	 to	 Tarr	 et	 al	 and	Dong	 et	 al.	(Tarr 1998),	
(Dong 2002),	resulted	in	a	total	of	eight	averaged	MOSFET	samples.		
,   ( )
here D is do e in (mGy) and n is the number of samples (exposures). The co ffici nt 
of determi ation was R2 = 0.99. The single sample (n = 1) low dose imit for the 
MOSFET dosimeter was 1.7 mGy (Fig. 4.1.3). Furthermore, solving equation (4) 
for the number of samples (n) and the setting dose (D) to the TLD low-dose limit 
(0.3 mGy), according to Tarr et al and Dong et al. (Tarr 1998), (Dong 2002), resulted 
in a total of eight averaged MOSFET samples. 
Fig. 4.1.3. The combined uncertainty (%) of MOSFET dosimeters as a function of dose and number of 
averaged samples (n = 1–16), 1.7 mGy one exposure low dose limit (n=1) and TLD comparable (0.3 mGy) 
low dose limit (n=8).
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4.2. VALIDATION OF MOSFET DOSE MEASUREMENT METHOD
4.2.1. MOSFET MEASUREMENTS AND MONTE CARLO SIMULATIONS
MOSFET dose measurements: The imaging volume (dental area) used for the 
MOSFET dose measurements ranged from the tip of the chin to the sinuses (Zref 
of 83 cm) and is presented in Fig. 4.2.1. 
Fig. 4.2.1. Coronal (A), axial (B) and sagittal (C) views of the RANDO phantom (vertical positioning at 
Zref 83 cm as shown in Fig. 3.6.1).
The effective dose in the imaging volume was 153 µSv. The major contributions 
to the effective dose originated from the remainder tissues (32%), salivary glands 
(21%), and thyroid gland (21%). The greatest contributors to the effective dose in the 
remainder tissues dose were the oral mucosa (24%) and extrathoracic airways (7%). 
The minimum and maximum effective dose in the typical imaging positions 
were 99 µSv (Zref of 84.5 cm) and 409 µSv (Zref of 78 cm), respectively. The effective 
dose contributions (µSv) of organs and the effective dose (µSv) determined in the 
RANDO phantom for Zref of 76 cm to 95 cm are presented in Fig. 4.2.2.
Fig. 4.2.2. Effective dose and effective dose contributions (wTHT) of some organs as a function of Zref 
in the RANDO phantom.
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Absorbed dose uncertainty: The type A uncertainty of absorbed dose was dependent 
on the dose level. The average dose and uncertainty evaluated from ten repeated 
measurements of twenty dosimeters is presented in Table 6. 
Table 6. The average of ten absorbed dose measurements and the dose uncertainty at the 95% 
confidence level 
Dosimeter
number
Dosimeter location
in phantom
Measured 
Dose (mGy)
Dose
uncertainty (%)
1 Calvarium anterior 0.17 36 %
2 Mid brain 0.2 31 %
3 Pituitary fossa 0.62 14 %
4 Right orbit 0.37 20 %
5 Right lens 0.27 25 %
6 Right cheek 3.34 6 %
7 Right ramus 4.77 5 %
8 Left ramus 5.27 5 %
9 Right parotid 4.35 5 %
10 Left parotid 4.53 5 %
11 Center C-spine 3.56 6 %
12 Left back neck 0.80 12 %
13 Right mandible body 1.58 8 %
14 Left mandible body 5.94 5 %
15 Right submandibular gland 5.37 5 %
16 Left submandibular gland 1.56 8 %
17 Center sublingula gland 1.58 8 %
18 Midline thyroid 0.97 11 %
19 Thyroid surface 0.67 13 %
20 Esophagus 0.79 12 %
Repeatability of MOSFET measurements: The RANDO phantom head was 
positioned in the CBCT x-ray centerline (Zref 83 cm). Repeatability calculations were 
performed by comparing the results of two measurements, including a new phantom 
placement, both consisting of the average doses of ten identical scans. Effective 
dose, organ dose contributions, and the variation percentage of measurement 1 
and measurement 2 are presented in Table 7.
42
4 Results 
Table 7. Repeatability of measurements of ICRP 103 effective dose and the contributions (wTHT) of 
various organ doses to the effective dose in the standard dental imaging case 
  Meas. 1 Meas. 2 Difference
Organs (µSv) (µSv) %
Salivary Glands 32.1 31.6 1.5%
Thyroid 32.0 32.8 -2.5%
Bone Marrow 24.7 25.2 -2.1%
Bone Surface 6.5 6.6 -2.1%
Esophagus 2.9 3.2 -7.1%
Brain 4.3 4.1 4.0%
Skin 0.7 0.7 -2.2%
Remainder 49.3 49.0 0.8%
   Lymphatic nodes 1.5 1.5 1.5%
   Extrathoracic airways 10.1 10.5 -3.8%
   Muscle 1.2 1.1 1.4%
   Oral mucosa 36.6 35.8 2.1%
Effective dose 152.5 153.2 -0.4%
Monte-Carlo simulations: MC simulations resulted in 136 µSv for the Zref of 83 cm. 
The largest contributions to the effective dose by MC simulations were from the 
remainder tissues (40%), salivary glands (31%), bone marrow (14%), and thyroid 
gland (6%). The overall effective dose variation in the measured height range was 
from 112 µSv (Zref of 79 cm) to 269 µSv (Zref of 74.0 cm). Fig. 4.2.3 shows the effective 
dose contributions of various organs and the effective dose as a function of Zref, as 
obtained from the MC simulations.
Fig. 4.2.3. Simulated effective dose and effective dose contributions of some organs as a function of Zref.
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Dose comparison: Table 8 presents the effective dose comparison at Zref of 83.0 
cm. A comparison was made between 20 averaged MOSFET dose measurements 
(Meas. 1 and Meas. 2 in Table 7) and MC simulation results.
  
Table 8. MOSFET and Monte-Carlo estimates of effective dose and dose contributions of various  
organs in the standard dental imaging case
  MOSFET MC Difference
Organs (µSv) (µSv) %
Salivary Glands 32 41 -22%
Thyroid 32 8.4 280%
Bone Marrow 25 18 40%
Bone Surface 6.5 6.9 -5.4%
Esophagus 3.0 0.4 600%
Brain 4.2 2.8 51%
Skin 0.7 1.0 -25%
Remainder 49 53 -7.3%
Effective dose 153 131 17%
4.2.2. MOSFET AND TLD COMPARISONS
The TLD effective doses ranged between 7.0 and 158.0 µSv and the MOSFETs doses 
between 6.1 and 175.0 µSv. The effective doses and the correlation coefficients (cc) are 
presented in Table 9. In addition, the effective dose and the organ dose contributions 
of radiosensitive organs, the difference percentages between the results, and the 
fractions of the effective dose obtained using MOSFET and TLD dosimeters of 
protocol no. 1 are presented in Table 10.
Table 9.  Effective doses (µSv), difference percentages and correlation coefficients (cc) attained using 
thermoluminescent dosimeter (TLD) (TLD 100, Thermo Fisher Scientific, Waltham, MA) and metal 
oxide semiconductor field-effect transistor (MOSFET) dosimeters using four different CBCT protocols
Number Protocol
FOV 
(cm)
TLD 
(µSv)
MOSFET 
(µSv)
Difference 
(%) cc
1 Face, maxillofacial 20 x 17 87,6 83,4 -5 0.99636
2 Teeth , upper jaw 8.5 x 5 7,0 6,1 -14 0.80801
3 Tooth, mandible 4 x 5 12,3 10,3 -16 0.98760
4 Teeth, both jaws 10 x 10 158,2 174,9 11 0.98994
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Table 10 MOSFET and TLD estimates of effective dose (µSv), dose contributions,
and fraction (%) of effective dose in Face (maxillofacial) FOV 20 x 17 cm protocol 
MOSFET TLD Difference MOSFET TLD
  (µSv) (µSv) (%) fraction Fraction
Bone Marrow 24.2 24.6 -2 % 29 % 28 %
Thyroid 11.4 11.4 0 % 14 % 13 %
Esophagus 1.2 1.3 -12 % 1 % 2 %
Skin 0.7 0.7 -3 % 1 % 1 %
Bone surface 2.0 2.0 -2 % 2 % 2 %
Salivary glands 10.6 10.4 2 % 13 % 12 %
Brain 12.2 13.2 -8 % 15 % 15 %
Remainder 21.2 24.0 -12 % 25 % 27 %
Lymphatic nodes 0.5 0.5 -7 % 1 % 1 %
Extrathor. airways 10.5 11.9 -12 % 13 % 14 %
Muscle 0.5 0.5 -11 % 1 % 1 %
Oral mucosa 9.8 11.0 -11 % 12 % 13 %
Effective dose 83.4 87.6 -5 % 100 % 100 %
Source variation: The CBCT source variation uncertainty was evaluated using two 
identical CBCT devices and the same full-face protocol 1 (face, maxillofacial; FOV, 
20 x 17 cm). The effective doses were 87.2 and 83.3 µSv resulting in a source 
variation of 5% (IV).
4.3. EFFECTIVE DOSES OBTAINED USING ONE MDCT DEVICE 
AND THREE CBCT DEVICES
Table 11 presents the effective dose and organ dose contributions of the most 
radiosensitive organs to the effective doses for the Planmed Verity CBCT scanner, 
the Promax 3D MAX, the i-CAT Next generation, and the Philips Brilliance 64 
MSCT devices.
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Table 11. ICRP 103 effective doses (µSv) and organ dose contributions  (wTHT) of  
various organ doses to the effective dose for CBCT and MSCT scanners
Planmed Verity 
(210º)
Promax i-Cat Philips
3D MAX Next Gen. Brlliance-64
Organ Oblique Prone Supine   Prone (210º)   (360º)   (360º)
Bone Marrow 40.5 48.1 68.4 42.7 49.7 158
Thyroid 16.6 27.8 48.1 16.4 22.0 261
Esophagus 1.6 3.5 4.3 2.1 2.4 25.4
Skin 0.9 1.1 1.9 0.9 1.1 4.3
Bone surface 10.6 12.6 17.9 3.6 13.0 41.4
Salivary 
glands 14.6 25.4 30.4 32.0 21.6 82.7
Brain 26.6 26.0 21.1 20.4 23.2 68.3
Remainder 22.7 47.2 54.9 49.7 36.9 140
Lymphatic 
nodes 0.7 1.2 1.4 1.5 1.0 3.8
Extrathoracic 
airw. 7.7 14.2 18.1 16.5 12.1 54.2
Muscle 0.6 1.2 1.5 1.4 1.0 4.0
Oral mucosa 13.8 30.6 33.9 30.3 22.8 78.0
Effective dose 134 192 247  168  170  781
4.4. EFFECTIVE DOSE UNCERTAINTIES
The combined measurement uncertainty, e.g. in the Face (FOV 20 x 17) protocol 
for a single dosimeter, varied between 16 and 21%. The tissue dose uncertainty was 
dependent on the dosimeter uncertainty and the estimated uncertainty of the fraction 
irradiated fi (25%). The tissue dose uncertainties of bone marrow, thyroid gland, 
esophagus, skin, bone surface, salivary glands, and brain were 25%, 24%, 34%, 20%, 
25%, 20%, and 21%, respectively. For the remainder tissues, the tissue uncertainties 
for lymphatic nodes, extrathoracic airways, muscles, and oral mucosa were 14%, 
18%, 14%, and 10%, respectively. The expanded effective dose uncertainties (2SD) 
were calculated as a weighted sum of the variances of all tissues. The results for 
the measured protocols were as follows: 20% for “Face” (FOV 20 x 17), 66% for 
“Teeth upper jaw” (8.5 x 5), 22% for “Teeth both jaws” (FOV 10 x 10 cm), and 42% 
for “Tooth mandible left molar” (FOV 4 x 5 cm). The combined uncertainties for 
all devices used in this study are presented in publications (III, IV, V)
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5 DISCUSSION
Since their introduction into maxillofacial imaging in 1997, CBCTs have become 
widely used by dentists and oral and maxillofacial surgeons (Ganguly 2009). To 
date, several methods have been proposed to reduce the effective doses in CBCT 
devices (Yu 2009). 
An awareness of the radiation risks has consequently led to the development of 
novel CBCT devices with decreased radiation output. At present, the most common 
method of reducing the effective dose is to reduce exposure parameters and the 
field of view. Moreover, the effective doses can be further reduced on CBCT devices 
with the addition of filtration that subsequently removes the lower energy spectra 
that contributes to the effective dose without improving image quality. Despite the 
tendency towards developing x-ray devices that produce lower effective doses, the 
radiation lifetime risk still remains difficult to assess. Therefore, newer, faster, and 
more effective methods for effective dose assessment are needed.
Traditional TLD measurement methods using anthropomorphic phantoms take 
approximately 1.5-2 hours to accomplish resulting in a maximum of 4-5 protocol 
measurements per working day. Since modern day CBCT devices can have up 
to 330 (Promax 3D MID) exposure protocols, several weeks of measurements 
are consequently required. By using MOSFET dosimeters, however, one dose 
measurement cycle takes only approximately two minutes. Therefore, depending 
on the required number of repetitions needed, a maximum of 80 protocols 
per working day can be measured. The MOSFET setup presented in this study 
provides a significant improvement in terms of time and effort, when compared 
with traditional TLDs.
The first aim of this thesis was to characterize MOSFET dosimeter sensitivity, 
energy, dose, and angular dependencies in order to assess the suitability of MOSFET 
dosimeters for low-dose CBCT measurements in anthropomorphic phantoms. A 
second aim was to develop and to validate a dose measurement system for effective 
dose assessment in anthropomorphic phantoms using Monte Carlo simulations and 
TLD measurements. The third aim was to apply the newly developed measurement 
system to assess the effective doses resulting from three CBCT and one MSCT device.
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5.1 MOSFET DOSIMETER CHARACTERIZATION FOR  
 DOSE DEPENDENCIES 
MOSFET dosimeters were characterized for CBCT photon energy ranges, dose 
properties, angular sensitivity, and dose uncertainties in studies I and II.
The energy dependency results of this study demonstrated that MOSFET dosimeter 
sensitivity was statistically independent of the mean photon energy ranges (34.2 
– 50.8 keV, 41.2 – 61.1 keV), that were attained using two filter combinations and 
tube potentials between 50 kVp and 90 kVp. 
A recent study by Manninen et al. (Manninen 2014a), investigated MOSFET 
(TN-1002RD) energy dependency using tube potentials between 40 kVp and 125 
kVp. Compared with the reference dosimeter value, they observed a 6% coefficient 
of variation for tube potentials between 60 and 110 kVp: a -10% decrease at 40 kVp 
and a -14.6% decrease at 125 kVp, respectively. These differences are explained by 
the lower number of exposures applied (5 versus 10), the lower dose (5 mGy versus 
17 mGy/20 mGy), which affected the uncertainty, different mean photon energy 
(keV) range and finally by the different thickness (10 mm) of the backscatter material 
that was used in their study. Likewise, another factor that could help explain the 
differences may have been the different dosimeter attenuation characteristics caused 
by the reinforcement of the dosimeter type (TN-1002RD-H) used in this study. 
In an earlier study by Dong et al. (Dong 2002), the photon energy response of 
MOSFET dosimeters was evaluated for skin dose measurements using tube voltages 
between 40 and 125 kVp (Eave= 26.5 – 39.7 keV). Their study resulted in a 20% 
decrease in sensitivity from 40 kVp to 90 kVp. The different energy range and the 
water backscatter material used by Dong et al. may well explain the differences 
when compared to the statistically insignificant sensitivity variations observed in our 
study. Furthermore, a study by Peet el al. (Peet 1999) evaluated the energy sensitivity 
of MOSFETs over a range of 60 – 100 kVp for diagnostic purposes. The photon 
energy sensitivity varied between 2.2 mV/mGy – 2.9 mV/mGy. The results of their 
study showed -20% lower sensitivity at 60 kVp compared with the (normalized) 90 
kVp value. The lower sensitivity results may also have been caused by the different 
orientation of the MOSFET epoxy bulbs that faced towards the water backscatter 
material.  In this thesis, the epoxy bulbs were directed towards the x-ray source 
to attain the highest sensitivity based on a previous study by Koivisto et al. (II). 
In a previous study Bower et al. (Bower 1998) characterized MOSFET dosimeter 
energy dependency using a (roughly) constant dose and a tube voltage ranging 
between 40 – 140 kVp.  Their choice of the constant dose, PMMA backscatter 
material, and ionization chamber reference dosimeter resulted in comparable values 
to those attained in our study when the results of both studies were normalized to 
90 kVp tube voltage.
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In this thesis the MOSFET dosimeter dose dependency (linearity) was evaluated 
using a dose range of 0.24–17.5 mGy. The results demonstrated that MOSFET 
dosimeters can be used without dose dependency correction factors for low dose 
(0.24–17.5 mGy) measurements. The results were comparable with the findings of 
Dong et al. (Dong 2002) and Bower et al. (Bower 1998). 
The MOSFET dose rate dependency was assessed using 0.16 – 2.70 mGy/s dose 
rates. No statistically significant variation in the sensitivity at different dose rates 
was observed, and therefore no dose rate correction was needed (Izewska 2005). 
The MOSFET dosimeter sensitivity was assessed as a function of the accumulated 
dose over a 9.200 mV threshold voltage range. This resulted in a 1% decrease of 
sensitivity per 1000 mV threshold voltage, which is in good agreement with the 
findings of Brady et al. (Brady 2012) and Toncheva et al. (Toncheva 2010).  The 
point doses obtained in the anthropomorphic RANDO phantom using MOSFET 
dosimeters resulted in a (-8%) lower average point dose (1.10 mGy) value than that 
obtained using TLD dosimeters (1.19 mGy). This (-8%) difference can be explained 
by a loss of MOSFET sensitivity previously described Brady et al. (Brady 2012) (≈1% 
per 1000 mV) and Toncheva et al. (Toncheva 2010) (≈3% per 3000 mV) and by the 
(≈9200 mV) increase in the accumulated threshold voltage between the calibration 
and the phantom measurements. 
The dosimeter (1SD) uncertainties in the phantom measurements ranged between 
26% (0.24 mGy) and 7% (2.29 mGy) using 10 averaged samples. Furthermore, 
the combined (point dose) (1SD) uncertainty, calculated as the weighted sum of 
variances ranged between 17% and 30%. All TLD and MOSFET point dose values 
except for those in the left and right submandibular glands were within the range 
covered by the extended (2SD) combined MOSFET uncertainty (Uc). The higher 
MOSFET doses observed in the left and right submandibular glands could be due 
to the vertical position variations of the dosimeters in their designated phantom 
holes: the surrounding mandible bones may have also caused different attenuation 
and scatter profiles to the dosimeters.
5.2. MOSFET DOSIMETER UNCERTAINTY 
In this thesis the MOSFET dosimeter uncertainty was evaluated to define the single 
sample low-dose limit (25% uncertainty, k=2) and to assess the number of exposures 
needed to attain the previously proposed TLD (1 exposure) low-dose (0.3 mGy) 
limit. The purpose of this study was to also assess the MOSFET sensitivity for 
different energy ranges and to compare the MOSFET point dose results with those 
obtained using TLDs.
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According to the findings of this thesis, the TLD comparable low dose limit (0.3 
mGy) can be achieved by averaging eight MOSFET exposures. When comparing the 
single-sample, low-dose detection limit of MOSFET dosimeters (1.40 mGy) attained 
by Yoshizumi at al. (Yoshizumi 2007) with the dose obtained in this study (1.69 
mGy), the results showed a 21% higher dose value. The difference in results could 
be caused by MOSFET sensitivity decrease due to a higher 120 kVp compared to the 
80 kVp used in this study. In a prior study performed by Peet et al. (Peet 1999), the 
observed minimum (25% total uncertainty, k=2) dose was 1.5 mGy when MOSFET 
detectors were evaluated for entrance surface dose measurements. Their 11% lower 
value could have been caused by the water backscatter material which has a lower 
backscatter factor (BSF) than the PMMA used in this study. 
5.3. VALIDATION OF THE MOSFET DOSE  
 MEASUREMENT SETUP
Monte-Carlo simulation: A novel mobile MOSFET dosimetry setup was developed 
and used to determine organ and effective dose in the maxillofacial area using an 
anthropomorphic RANDO head phantom. The purpose was also to compare the 
experimental MOSFET results with Monte Carlo (MC) simulations.
In the standard dental imaging mode (Zref of 83 cm), the observed difference between 
the effective dose obtained using 20 MOSFET dosimeters and the corresponding MC 
simulations was relatively small, 17%. The effective dose difference was between ± 
25% for Zref from 82 cm to 87 cm covering the most commonly used maxillofacial 
imaging regions. The differences between simulations and measurements can 
be explained by the differences in the mathematically modeled and physically 
realized phantoms, the necessity of having to rely on a limited number of 20 
point measurements, and the method of assessing organ doses based on the 
measurements. Furthermore the differences in the thyroid gland and esophagus 
effective dose contributions obtained using MOSFET dosimeters and Monte Carlo 
simulations (Table 8) can be explained by the differences in the organ positions 
in relation to the exposed volume which subsequently had a minor effect to the 
effective dose. 
The findings in this study demonstrate that individual patient anatomy and 
positioning have a drastic effect on the overall effective dose. The area most affected 
by the vertical positioning of the beam was the transition zone between the lower 
part of the oral cavity and the thyroid gland. A minor change in patient positioning 
in the designated area subsequently increased the dose by 16% (III).
Another observation was that there seems to be an optimal height both in the 
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physical phantom and in the Cristy-Eckerman model where the effective dose has 
a minimum value. This information may be useful for dose reduction when using 8 
x 8 cm imaging volume. The positioning of patients to an x-ray beam is a decision 
that is based on clinical needs. It is, however, especially important to avoid any 
exposure of the thyroid gland region because exposure to this area rapidly increases 
the effective dose.
MOSFET-TLD: In this thesis the MOSFET dose measurement setup was validated 
for effective dose assessment in the maxillofacial region. This was accomplished by 
comparing MOSFET results to TLD reference values obtained in identical conditions.
To date, TLDs are the most commonly used dosimeters in dose measurement 
studies due to their sensitivity and small size (Davis 2003). Furthermore, TLDs 
are often used for effective dose assessments (Ludlow 2003), (Ludlow 2006), 
(Roberts 2009), (Suomalainen 2009), (Rottke 2013). Nevertheless, TLDs have 
certain limitations especially when a small number of dosimeters are used in 
point-dose measurements (Pauwels 2010). TLDs and MOSFETs are sensitive to 
phantom tilting (III), and therefore minor shifts in the FOV can have a significant 
impact on the effective dose results (IV). Previous studies using TLDs have also 
reported differences between the x-ray sources, phantoms, phantom positioning, 
and placement of the dosimeters in the phantoms.
In order to minimize the above discussed dosimeter limitations, the following 
precautions were undertaken in this thesis: all measurements were performed using 
the same CBCT device to minimize the source variations; only one anthropomorphic 
phantom was used in this study offering equal attenuation and scattering conditions; 
identical TLD and MOSFET dosimeter positions were used in the phantom head; the 
phantom head was specially fixed to the CBCT device to allow exact repositioning 
after replacing the dosimeters in the phantom. In addition, the positioning of the 
acquisition volume in each case was verified using a reconstructed 3D image of the 
anatomical structures in the FOV.
In order to avoid any inaccuracies induced by the limited number of exposed 
dosimeters in the small FOV, the organ dose contributions were assessed using 
the full-face protocol no. 1 (Face, maxillofacial, FOV 20 x 17 cm). The large FOV 
protocol yielded 5% less effective dose values in the MOSFETs when compared with 
the TLDs. The largest differences in the effective dose contributions were measured 
in the remainder tissues (-12%) and esophagus (-12%). These differences could be 
due to minor variations in the phantom positioning, as previously discussed. 
When comparing the effective doses acquired using protocol no. 2 (teeth upper 
jaw, FOV 8.5 x 5 cm), the MOSFET dosimeters recorded 14% lower effective dose 
(6.1 µSv) values than the TLD dosimeters (7.0 µSv). The largest difference between 
MOSFET and TLD measurements were observed in the thyroid gland (MOSFET: 1.5 
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µSv, TLD: 0.7 µSv: +121%). The largest difference in the effective dose contribution 
was attained in the remainder tissues  (MOSFET: 1.9 µSv, TLD: 3.0 µSv: -36%). The 
higher effective dose observed in the thyroid gland and the lower values attained 
in the remainder tissues are possibly due to the unintended vertical shifting of the 
FOV position between different TLD and MOSFET measurements. 
The limited number of dosimeters used in this study and the uncertainty of 
the doses measured near the x-ray field edge may have caused the differences in 
the small FOV results. Pauwels et al. have previously observed this phenomenon 
(Pauwels 2010). The greatest effective dose contribution difference was observed in 
the thyroid gland. When comparing the source variation using two CBCT devices, 
only minor differences of 5% in the effective doses were observed. This could be an 
indication of position differences between two MOSFET set-ups. However, it must 
be noted that the mean effective dose variation between the measured protocols 
using MOSFET and TLD methods was only 2%.
5.4. MOSFET DOSE MEASUREMENT SETUP APPLICATION
In the present study, organ and effective doses were assessed in three different 
phantom head positions using a Planmed Verity CBCT scanner that has recently 
been approved for maxillofacial imaging. The device uses a partial 210º gantry scan 
and generates an asymmetric and non-equivalent dose distribution in the phantom 
head that makes it necessary to assess the effective dose in different positions. The 
Planmed Verity effective doses obtained in the supine position were 29% higher 
(247 µSv) than those obtained in the prone position (192 µSv). Furthermore, when 
the prone and oblique positions were compared, the effective dose in the oblique 
position was 30% lower. 
When compared with the dental reference CBCT in the prone position, the 
Planmed Verity CBCT scanner yielded a 14% higher effective dose compared with 
the Promax 3D MAX. The difference (24 µSv) can be well explained by the larger 
field of view and the smaller focus-to-target distance of the Planmed Verity CBCT 
scanner. The contributions of organs to the effective dose between the devices were, 
however, different. More specifically, when exposed using the Planmed Verity CBCT 
scanner, the thyroid gland and the bone surface presented slightly higher organ doses 
than those of the Promax 3D MAX and subsequently demonstrates the differences 
in the imaging geometry and FOV size.
Another reference effective dose (170 µSv) for comparison in the prone position 
was attained using an i-Cat Next Generation CBCT device. In the comparison, 
the Planmed Verity CBCT scanner resulted in a 13% higher effective dose. The 
difference is mainly due to the effective dose contributions in the thyroid gland, 
52
5 Discussion
salivary glands, and remainder tissues. In this study, the effective dose for the i-Cat 
Next Generation CBCT device was obtained in the high-resolution mode (170 µSv, 
120 kVp, 37 mAs) that is found to double the effective dose4. The obtained value 
is comparable, when scaled by current-exposure-time product, to the results of 
previous studies by Pauwels (Pauwels 2010) et al. (83 µSv, 120 kVp, 18.5 mAs) and 
Ludlow et al. (Ludlow 2008) (87 µSv, 120 kVp, 19 mAs).
Finally, effective doses were assessed using a MSCT device resulting in an 
effective dose of 781 µS. In a previous study by Loubele et al. (Loubele 2008), the 
MSCT effective dose varied between 995 µSv and 1160 µSv. These results were, 
however, obtained using a 22.5 cm scan length while the scan length used in this 
study was 18 cm. In order to compare our results with the previous studies, we 
scaled down the scan length from 22.5 cm to 18 cm resulting in effective doses 
between 796 µSv and 928 µSv. These were, however, between 2% to 19% higher 
than the 781 µSv of this study. 
There are certain limitations in this thesis. The limited number of dosimeters 
used in this thesis could be a potential source of error. In a recent study by Pauwels 
(Pauwels 2013) that focused on the impact of dosimeter quantity on the effective dose 
assessment, it was demonstrated that a large number of dosimeters are needed for 
accurate dose estimation in particular for red bone marrow, thyroid gland, salivary 
glands, and remainder tissues.
Another possible source of error in this study were the differences in the estimated 
irradiated organ fractions. The estimated amount of bone marrow (Cristy 1987) was 
also a potential source of error when the age-dependent variations of bone marrow 
are considered. A further weakness of this study is that the thyroid gland may not 
be fully contained in phantom layer 9 (Fig. 3.3.1) but in the lower layers 10 and 11, 
which may have caused an error in the dose assessment.
Therefore, an interpretation of the results should be carried out with care 
since the results were obtained using the manufacturer-recommended imaging 
parameters without taking image quality in terms of contrast, noise sharpness, or 
diagnostic value into account. 
5.5. FUTURE DEVELOPMENTS IN EFFECTIVE  
 DOSE ASSESSMENT 
The accuracy of the MOSFET dose assessment setup developed in this thesis could 
be further improved by increasing the number of dosimeters to around 150 as 
proposed by Pauwels et al. (Pauwels 2010). An increased number of dosimeters is 
especially important in small FOVs where the subsequent number of dosimeters is 
limited. To date, the MOSFET dosimeter flexible wire has a limited length of 200 
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mm, which subsequently restricts the positioning of dosimeters in the upper part 
of the phantom. Furthermore, in the present setting, the number of cables that 
can be routed through the phantom base are limited to 20 dosimeter cables due to 
the size of the entry void. These shortcomings can be improved by increasing the 
length of the flexible wire to approximately 300 mm to allow for the placement of 
the dosimeters in the cranial area.
To date, the MOSFET software used in this study allows individual dosimeter 
calibration coefficient adjustment. However, the results of this study and the findings 
of Brady et al. (Brady 2012) and Toncheva et al. (Toncheva 2010) showed that in 
order to improve the accuracy there is need for user-adjustable, cumulative dose 
correction coefficient. Such a correction coefficient could be implemented into the 
TN-RD-75M software used in this study.
Although MOSFET dosimeters are easy to use, they have a limited life expectancy. 
Therefore, alternative electronic dosimeters with infinite lifespans should be 
developed.
The different absorbed dose profiles attained within the phantom using 
different vertical patient positions (III) and CBCT scan directions (V) revealed new 
possibilities for dose reduction that should be further investigated. 
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6 Conclusions
6 CONCLUSIONS
In this thesis, a real time low-dose measurement setup using MOSFET dosimeters 
was developed to match the growing need for the assessment of effective doses 
in the increasing number of dental CBCT devices and protocols used worldwide. 
Moreover, the novel setup developed in this thesis can be applied in hospitals and 
other clinical settings to monitor the protocol-specific effective doses induced by 
different dental CBCTs.
The MOSFET dosimeter characterization presented good dose linearity and 
statistically insignificant energy dependency for the investigated dental energies. 
However, due to their variation in angular sensitivity, MOSFET dosimeters should 
always be calibrated in the actual clinical settings for the beam geometry and angular 
range of the CBCT exposure. The results of the validation procedure confirmed that 
the developed MOSFET dose measurement setup is capable of producing similar 
results to those attained using the MC simulation program. Furthermore, when 
taking into account the uncertainties of TLD and MOSFET measurement methods 
and the results of the statistical analysis, the effective doses acquired using MOSFET 
dosimeters were found to be in good agreement with those obtained using TLD 
dosimeters. When compared with the previously used methods, the major benefit 
of the setup developed in this thesis is its ability to acquire the effective dose values 
in a fraction of the time needed when using TLDs. Such an increase in effective 
dose acquisition speed makes the extensive series of CBCT dose measurements in 
anthropomorphic phantoms feasible.
In future, there will be a growing tendency to perform the effective dose 
assessment using simulations that are based on 3D models. The MOSFET setup 
presented in this thesis with its point dose values will serve as an excellent validation 
method for such future developments. 
In summary, the fast and dependable low dose measurement setup developed 
and presented in this thesis provides an effective means of CBCT dose assessment 
using a variety of dental protocols.
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